Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.4K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.4K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.0K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.0K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.2K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.2K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
Epigenetic Regulation01:37

Epigenetic Regulation

3.5K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurable Metrics of Mesenchymal Stem Cell Aging.

Sovremennye tekhnologii v meditsine·2025
Same author

Fate of Transplanted Allogeneic Mesenchymal Stromal Cells in the Rat Spinal Cord under Normal Conditions and during the Acute Phase of Spinal Cord Contusion Injury.

Bulletin of experimental biology and medicine·2025
Same author

Migration of Regulatory T Cells to the Peritumor Microenvironment of Experimental Glioblastoma.

Sovremennye tekhnologii v meditsine·2025
Same author

Efficacy Evaluation of "Enhanced" Natural Killers with <i>CISH</i> and <i>B2M</i> Knockouts on Viability and Metabolic Status of 3D Glioblastoma Spheroid Cells in Patients.

Sovremennye tekhnologii v meditsine·2025
Same author

Management of radiation-induced proctitis using submucosal endoscopic injections of autologous adipose-derived stromal vascular fraction: a case report.

Stem cell research & therapy·2024
Same author

Development of a 3D Tumor Spheroid Model from the Patient's Glioblastoma Cells and Its Study by Metabolic Fluorescence Lifetime Imaging.

Sovremennye tekhnologii v meditsine·2023

Related Experiment Video

Updated: Dec 6, 2025

Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts
08:45

Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts

Published on: March 18, 2016

7.1K

Cell Reprogramming Preserving Epigenetic Age: Advantages and Limitations.

E M Samoylova1, V P Baklaushev2

  • 1Federal Research Clinical Center, FMBA of Russia, Moscow, 115682, Russia. samoyket@gmail.com.

Biochemistry. Biokhimiia
|October 14, 2020
PubMed
Summary

Cell aging involves DNA methylation changes, impacting epigenetic age. Two reprogramming methods, iPSC and transdifferentiation, affect epigenetic age differently, crucial for regenerative medicine and disease modeling.

More Related Videos

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells
08:01

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells

Published on: August 29, 2020

2.5K
Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.1K

Related Experiment Videos

Last Updated: Dec 6, 2025

Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts
08:45

Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts

Published on: March 18, 2016

7.1K
A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells
08:01

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells

Published on: August 29, 2020

2.5K
Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.1K

Area of Science:

  • Cellular Biology
  • Epigenetics
  • Regenerative Medicine

Background:

  • Cell aging, discovered in 1961, is linked to telomere shortening and DNA methylation changes.
  • Epigenetic age is a key factor in cell reprogramming technologies like induced pluripotent stem cells (iPSC) and transdifferentiation.
  • Understanding DNA methylation's role in neural development, function, and aging is vital for CNS pathology models.

Purpose of the Study:

  • To compare the effects of iPSC-based and transdifferentiation-based cell reprogramming on epigenetic age.
  • To highlight the importance of understanding DNA methylation in the context of aging and neurological diseases.
  • To emphasize direct cell reprogramming as a valuable approach for regenerative medicine and cell replacement therapy.

Main Methods:

  • Comparison of DNA methylation profiles between iPSC and transdifferentiation reprogramming methods.
  • Analysis of epigenetic age changes associated with different reprogramming strategies.
  • Review of the biological roles of DNA methylation in neural development and aging.

Main Results:

  • iPSC reprogramming generally reverts DNA methylation profiles to a less differentiated state.
  • Direct transdifferentiation protocols tend to preserve the original DNA methylation profiles.
  • Both methods offer distinct advantages for cell-based therapies and disease modeling.

Conclusions:

  • Direct cell reprogramming is a valuable alternative/supplement to iPSC technology for generating mature cells.
  • Optimizing patient-specific cell production requires considering the epigenetic age of starting materials.
  • Advancements in regenerative and personalized medicine depend on refining reprogramming strategies for epigenetic age control.